ArticleJournal of translational autoimmunity2021

S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases.

Fanny Duguet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.